Home/Filings/4/0001209191-23-057640
4//SEC Filing

LEVIN JEREMY M 4

Accession 0001209191-23-057640

CIK 0001636651other

Filed

Dec 5, 7:00 PM ET

Accepted

Dec 6, 5:05 PM ET

Size

8.0 KB

Accession

0001209191-23-057640

Insider Transaction Report

Form 4
Period: 2023-12-04
LEVIN JEREMY M
DirectorCEO
Transactions
  • Gift

    Common Stock

    2023-12-04573,2754,171,742 total
  • Gift

    Common Stock

    2023-12-04573,2753,598,467 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    35,461
Footnotes (3)
  • [F1]The reporting executive has transferred shares to a family trust for the benefit of his children as part of generational estate planning. The reporting executive has made these transfers for no consideration. The reporting executive does not serve as the trustee of the family trusts, nor does he maintain investment control over, or have a pecuniary interest in, the shares.
  • [F2]This direct ownership total corrects an inadvertent administrative error in the number of shares of common stock that were reported as directly held on the Form 4 filed by the reporting executive on September 1, 2020. Before the transactions reported herein, the reporting executive held 4,745,017 shares of common stock directly
  • [F3]The reportable securities are owned directly by Divo Holdings, LLC ("Divo"). The reporting executive's spouse is the manager of Divo. The reporting executive disclaims beneficial ownership of the shares held by Divo and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose.

Issuer

Ovid Therapeutics Inc.

CIK 0001636651

Entity typeother

Related Parties

1
  • filerCIK 0001256153

Filing Metadata

Form type
4
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 5:05 PM ET
Size
8.0 KB